USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 192 filers reported holding USANA HEALTH SCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $205,006 | -2.4% | 3,252 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $210,023 | -8.3% | 3,339 | +5.5% | 0.00% | 0.0% |
| Q2 2022 | $229,000 | -8.8% | 3,165 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $251,000 | -23.2% | 3,157 | -2.3% | 0.00% | 0.0% |
| Q4 2021 | $327,000 | +7.2% | 3,232 | -2.3% | 0.00% | 0.0% |
| Q3 2021 | $305,000 | -13.1% | 3,307 | -3.6% | 0.00% | -33.3% |
| Q2 2021 | $351,000 | -2.2% | 3,431 | -6.6% | 0.00% | 0.0% |
| Q1 2021 | $359,000 | +27.3% | 3,675 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $282,000 | +0.7% | 3,657 | -3.9% | 0.00% | 0.0% |
| Q3 2020 | $280,000 | +30.8% | 3,804 | +30.4% | 0.00% | 0.0% |
| Q2 2020 | $214,000 | -67.5% | 2,918 | -65.1% | 0.00% | -62.5% |
| Q4 2019 | $658,000 | -36.5% | 8,371 | -44.8% | 0.01% | -38.5% |
| Q3 2019 | $1,037,000 | -36.0% | 15,161 | -25.7% | 0.01% | -31.6% |
| Q2 2019 | $1,620,000 | – | 20,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DENALI ADVISORS LLC | 50,729 | $3,190,854 | 1.33% |
| Cypress Capital, LLC | 12,227 | $769,078 | 0.25% |
| DGS Capital Management, LLC | 6,835 | $429,922 | 0.24% |
| PZENA INVESTMENT MANAGEMENT LLC | 818,384 | $51,476,354 | 0.22% |
| WINTON GROUP Ltd | 26,950 | $1,695,155 | 0.10% |
| Renaissance Technologies | 1,211,797 | $76,222 | 0.10% |
| Covestor Ltd | 1,602 | $101 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 267,057 | $16,778 | 0.07% |
| Ifrah Financial Services, Inc. | 3,368 | $211,847 | 0.07% |
| CAXTON ASSOCIATES LP | 5,928 | $372,871 | 0.06% |